Robert Ford, Chairman and CEO, reported organic sales growth of 7.5% excluding COVID test sales, highlighting double-digit growth in Medical Devices and high single-digit growth in Established ...
DiaSorin's 2024 revenue grew by 3%, with an underlying increase of 7%, and net profit rose to 188.1M EUR, reflecting a 17% EPS increase. The company generated strong free cash flow of 191M EUR, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback